Altimmune, Inc. (ALT)
2.855
-0.06
(-2.06%)
USD |
NASDAQ |
May 15, 16:00
2.86
0.00 (0.00%)
After-Hours: 20:00
Altimmune Total Liabilities (Quarterly) : 51.64M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 85.38B |
| Madrigal Pharmaceuticals, Inc. | 683.87M |
| Amgen, Inc. | 83.31B |
| Verastem, Inc. | 146.03M |
| Karyopharm Therapeutics, Inc. | 397.06M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 335.63M |
| Shareholders Equity (Quarterly) | 283.99M |
| Debt to Equity Ratio | 0.1262 |
| Current Ratio | 29.54 |
| Net Debt Paydown Yield | -1.70% |